Zoliget®

  • All Products
  • By Generic
  • By Therapeutic Segment

Zoliget®

Therapeutic Segment: Anti-Diabetic

Generic Name: Pioglitazone HCl + Glimepiride

Indication:

As an adjunct to diet and exercise for the improvement of glycemic control in patients with type 2 diabetes mellitus who are already treated with pioglitazone and a sulfonylurea and whose diabetes is not adequately controlled with glimepiride alone or those patients who have initially responded to pioglitazone alone and require additional glycemic control.

Available as:

Tablets
  • 30MG + 2MG
  • 30MG + 4MG